Toggle light / dark theme

A team of researchers at OpenAI, a San Francisco artificial intelligence development company, has added a new module to its GPT-3 autoregressive language model. Called DALL·E, the module excerpts text with multiple characteristics, analyzes it and then draws a picture based on what it believes was described. On their webpage describing the new module, the team at OpenAI describe it as “a simple decoder-only transformer” and note that they plan to provide more details about its architecture and how it can be used as they learn more about it themselves.

GPT-3 was developed by the company to demonstrate how far could take text processing and creation. It analyzes user-selected text and generates new text based on that input. For example, if a user types “tell me a story about a dog that saves a child in a fire,” GPT-3 can create such a story in a human-like way. The same input a second time results in the generation of another version of the story.

In this new effort, the researchers have extended this ability to graphics. A user types in a sentence and DALL·E attempts to generate what is described using graphics and other imagery. As an example, if a user types in “a dog with cat claws and a bird tail,” the system would produce a cartoon-looking image of a dog with such features—and not just one. It would produce a whole line of them, each created using slightly different interpretations of the original text.

Trip Planning

With their AI approximation for psychedelic trips in place, the team says they can start to probe for similarities with how the human brain processes drugs, citing the structural similarity between neural nets and the human visual cortices.

“The process of generating natural images with deep neural networks can be perturbed in visually similar ways and may offer mechanistic insights into its biological counterpart — in addition to offering a tool to illustrate verbal reports of psychedelic experiences,” Schartner told PsyPost.

The explosive growth of artificial intelligence calls for rapidly increasing computing power. Two reported photonic processors could meet these power requirements and revolutionize artificial-intelligence hardware. Advances in integrated photonic computer processors.

Research papers come out far too rapidly for anyone to read them all, especially in the field of machine learning, which now affects (and produces papers in) practically every industry and company. This column aims to collect the most relevant recent discoveries and papers — particularly in but not limited to artificial intelligence — and explain why they matter.

Scientists have developed a machine-learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed.

The intent of this work is to speed up repurposing, which is not a new concept—think Botox injections, first approved to treat crossed eyes and now a migraine treatment and top cosmetic strategy to reduce the appearance of wrinkles.

But getting to those new uses typically involves a mix of serendipity and time-consuming and expensive randomized to ensure that a drug deemed effective for one disorder will be useful as a treatment for something else.

Scientists at DGIST in Korea, and UC Irvine and UC San Diego in the US, have developed a computer architecture that processes unsupervised machine learning algorithms faster, while consuming significantly less energy than state-of-the-art graphics processing units. The key is processing data where it is stored in computer memory and in an all-digital format. The researchers presented the new architecture, called DUAL, at the 2020 53rd Annual IEEE/ACM International Symposium on Microarchitecture.

“Today’s computer applications generate a large amount of data that needs to be processed by algorithms,” says Yeseong Kim of Daegu Gyeongbuk Institute of Science and Technology (DGIST), who led the effort.

Powerful “unsupervised” machine learning involves training an algorithm to recognize patterns in without providing labeled examples for comparison. One popular approach is a clustering algorithm, which groups similar data into different classes. These algorithms are used for a wide variety of data analyzes, such as identifying on social media, filtering spam email and detecting criminal or fraudulent activity online.

Proteins are essential to cells, carrying out complex tasks and catalyzing chemical reactions. Scientists and engineers have long sought to harness this power by designing artificial proteins that can perform new tasks, like treat disease, capture carbon or harvest energy, but many of the processes designed to create such proteins are slow and complex, with a high failure rate.

In a breakthrough that could have implications across the healthcare, agriculture, and energy sectors, a team lead by researchers in the Pritzker School of Molecular Engineering at the University of Chicago has developed an artificial intelligence-led process that uses big data to design new proteins.

By developing machine-learning models that can review protein information culled from genome databases, the researchers found relatively simple design rules for building artificial proteins. When the team constructed these artificial proteins in the lab, they found that they performed chemical processes so well that they rivaled those found in nature.

Unmanned Aerial Vehicles (UAV), commonly referred to as drones, may prove to be a valuable tool in the battle against pandemics like COVID-19. Researchers at the University of Calgary, the Southern Alberta Institute of Technology (SAIT), Alberta Health Services (AHS) and Alberta Precision Laboratories (APL) are partnering with the Stoney Nakoda Nations (SNN) to deliver medical equipment and test kits for COVID-19 to remote areas, and to connect these communities to laboratories more quickly using these remotely piloted aircraft.

Access for all

“We know that testing for COVID-19 is one of our most effective tools against its spread. Many remote communities in Canada do not have easy access to testing centres and medical supplies to support rapid testing and containment. Drones can help us respond to that need,” says Dr. John Conly, MD, medical director of the W21C Research and Innovation Centre at the Cumming School of Medicine (CSM) and co-principal investigator on the project.